Related Experiment Video
Updated: Jul 29, 2025

09:29
Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
7.5K
Transcriptomic Comparison of Human Peripartum and Dilated Cardiomyopathy Identifies Differences in Key Disease
Jude Taylor1, Anna C Y Yeung2, Anthony Ashton3
1Centre for Healthy Futures, Torrens University Australia, Surrey Hills, NSW 2010, Australia.
Journal of Cardiovascular Development and Disease
|May 26, 2023
Summary
Peripartum cardiomyopathy (PPCM) and dilated cardiomyopathy (DCM) share heart failure pathways. PPCM uniquely involves Golgi vesicle changes and less immune cell activity than DCM.
Area of Science:
- Cardiology
- Genomics
- Molecular Biology
Background:
- Peripartum cardiomyopathy (PPCM) is a rare heart failure during pregnancy.
- A subset of PPCM patients develop end-stage heart failure similar to dilated cardiomyopathy (DCM).
Purpose of the Study:
- To compare gene expression profiles of end-stage PPCM with female DCM and healthy donors.
- To identify shared and unique molecular pathways in PPCM and DCM.
Main Methods:
- Analysis of two independent RNA-seq datasets from left ventricles.
- Differential gene expression, enrichment analysis, and cellular deconvolution.
Main Results:
- PPCM and DCM share metabolic and extracellular matrix remodeling pathways.
- PPCM exhibits enriched Golgi vesicle biogenesis pathways, not seen in DCM.
- Immune cell population changes are less pronounced in PPCM than in DCM, which shows significant pro-inflammatory T cell activity.
Conclusions:
- End-stage PPCM and DCM share common heart failure mechanisms.
- Unique pathways, including Golgi vesicle biogenesis, may distinguish PPCM.
- Distinct immune responses are observed between PPCM and DCM.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
12
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17

